HIGHLIGHTS
- who: Seung S. Lee et al. from the Division of Experimental Medicine, McGill University, Montreal, QC H A , Canada have published the Article: Functionalized Carbon Nanoparticles as Theranostic Agents and Their Future Clinical Utility in Oncology, in the Journal: Bioengineering 2023, 10, 108. of /2023/
- what: BIND-014 was well-tolerated in safety studies, with 30% of the 42 prostate cancer patient in the trial showing a u226550% decline in PSA levels .
- future: Investigations are required to fully understand the effects of internalization and cytotoxicity associated with carbon-based nanomaterials. As nanoparticles are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.